Menu
SOPHiA GENETICS™ is excited to be a part of the American College of Medical Genetics annual meeting, held in person in Salt Lake City, Utah, from March 14th–18th.
You will have the chance to chat with our experts at booth #407 and demo the universal SOPHiA DDM™ Platform.
User cases: advancing rare disease research with the SOPHiA DDM™ Platform
Exhibit Theatre 2
Thursday, March 16
11:55 am - 12:25 pm
Join us for a presentation describing how different SOPHiA GENETICS™ Applications can be used in laboratories for analysis of variants associated with rare diseases and hereditary cancers, and the value of purpose-built, high-quality enrichment kits, data analytics, and interpretation software for targeted panels and exome sequencing.
Presented by:
Sevana Yaghoubian, MSc – Director, Genomics, SOPHiA GENETICS
Simon Alfred, PhD – Senior Subject Matter Expert – SOPHiA GENETICS
Melania Abreu, MD, MSc – Medical Geneticist, Genos Médica
A next generation sequencing strategy for a comprehensive molecular diagnosis in Chronic Lymphocytic Leukemia: Mexican Experience
Friday, March 17th
10:30 am – 12:00 pm
Poster #P042
First Author: Melania Abreu, MD, MSc - Medical Geneticist, Genos Médica
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
